Aker BioMarine ASA Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-22.8	182.6	-9	10	-8
Depreciation & Amortization	22.9	42.8	22.6	49.2	51
Other Amortization	-	-	-	2.2	2
Loss (Gain) From Sale of Assets	-	-	0.9	-	-
Asset Writedown & Restructuring Costs	0.1	1.2	-	-	5.8
Loss (Gain) on Equity Investments	2.4	-	3	-	-
Other Operating Activities	-7.9	9.5	-22.4	-8.3	-16.6
Change in Accounts Receivable	-5.8	-18.7	23	-38	-31.6
Operating Cash Flow	4.2	12.2	47.4	15.1	2.6
Operating Cash Flow Growth	-65.57%	-74.26%	213.91%	480.77%	-
Capital Expenditures	-6.3	-17.4	-45.9	-40.5	-78.7
Cash Acquisitions	-	-0.7	-	-11.1	-
Divestitures	-7.3	404.1	0.6	-	-
Sale (Purchase) of Intangibles	-2.8	-5.7	-3.4	-5.6	-2.4
Other Investing Activities	-	0.1	0.1	-	-
Investing Cash Flow	-17	379.4	-48.9	-56.4	-81.1
Short-Term Debt Issued	16.3	3.5	-	-	-
Long-Term Debt Issued	-	150.7	40	66.5	339.2
Total Debt Issued	16.3	154.2	40	66.5	339.2
Short-Term Debt Repaid	-	-	-18.7	-	-
Long-Term Debt Repaid	-1.6	-185	-14.6	-14.2	-260.3
Total Debt Repaid	-1.6	-185	-33.3	-14.2	-260.3
Net Debt Issued (Repaid)	14.7	-30.8	6.7	52.3	78.9
Issuance of Common Stock	-	-	-	0.2	-
Other Financing Activities	-0.1	-	-	-	-
Financing Cash Flow	14.6	-404	6.7	52.5	78.9
Miscellaneous Cash Flow Adjustments	0.1	-0.1	-	-	-
Net Cash Flow	1.9	-12.5	5.2	11.2	0.4
Free Cash Flow	-2.1	-5.2	1.5	-25.4	-76.1
Free Cash Flow Margin	-0.96%	-2.61%	0.76%	-9.16%	-29.04%
Free Cash Flow Per Share	-0.02	-0.06	0.02	-0.29	-0.87
Cash Interest Paid	15.8	24.3	29.7	17.6	12.8
Cash Income Tax Paid	-	-	0.7	2.8	-3.3
Levered Free Cash Flow	19.71	80.54	-24.85	-34.7	-49.05
Unlevered Free Cash Flow	28.4	82.1	-12.54	-22.01	-40.49
Change in Working Capital	-5.8	-18.7	23	-38	-31.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.